Wedbush Reiterates Outperform on SoundHound AI, Maintains $16 Price Target You are unauthorized to view this page. Username Password Remember Me Forgot Password
Baird Maintains Outperform on Doximity, Raises Price Target to $80 You are unauthorized to view this page.
Wells Fargo Maintains Equal-Weight on Masco, Raises Price Target to $80 You are unauthorized to view this page.
Wedbush Maintains Outperform on Revolution Medicines, Raises Price Target to $77 You are unauthorized to view this page.
Baird Maintains Neutral on Methode Electronics, Raises Price Target to $8.5 You are unauthorized to view this page.
Wells Fargo Maintains Overweight on Revolution Medicines, Raises Price Target to $70 You are unauthorized to view this page.
Baird Maintains Neutral on Portillos, Lowers Price Target to $7 You are unauthorized to view this page.
Wells Fargo Maintains Overweight on Travere Therapeutics, Raises Price Target to $35 You are unauthorized to view this page.
Baird Maintains Outperform on Chewy, Lowers Price Target to $48 You are unauthorized to view this page.
Wells Fargo Maintains Overweight on Mineralys Therapeutics, Raises Price Target to $50 You are unauthorized to view this page.
tm
tm